Skip to main content

Table 1 Clinical data of 40 cases

From: Study on the clinical application of pulsed DC magnetic technology for tracking of intraoperative head motion during frameless stereotaxy

Patient No.

appl. type & procedure

gender & age

diagnosis

localization

CT/MRI-data

FRE (mm)

1

A

m 28 y

glioma WHO III

left frontal

MRI

1,74

2

A

f 72 y

glioblastoma

left frontal

MRI

1,17

3

A

f 52 y

metastasis

right occipital

MRI

1,28

4

A

f 68 y

glioma WHO III

right parietal

MRI

2,16

5

A

f 81 y

glioblastoma

left parietal

MRI

1,57

6

A

f 56 y

metastasis

left temporal

MRI

1,65

7

A

f 73 y

metastasis

right frontal

MRI

1,36

8

A

m 30 y

metastasis

left temporal

MRI

0,91

9

A

m 61 y

glioblastoma

left parietal

MRI

1,37

10

A

m 60 y

glioblastoma

left parietal

MRI

1,84

11

B1 (MLL)

f 63 y

metastasis

left frontal/left parietal

MRI

2,11

12

B1 (MLL)

m 63 y

metastasis

right frontal/left temporal

MRI

1,24

13

B1 (MLL)

f 48 y

metastasis

left frontal/right frontal

MRI

1,85

14

B1 (MLL)

f 66 y

metastasis

left frontal/left occipital

MRI

1,44

15

B1 (SBP)

m 49 y

prim. bone tumour

skull base + orbita

CT

1,17

16

B2 (MLL)

f 67 y

metastasis

right frontal/right parietal

MRI

1,41

17

B2 (MLL)

f 68 y

metastasis

right frontal/right parietal

MRI

1,33

18

B2 (SBP)

m 54 y

meningioma

skull base + orbita

CT

1,24

19

B2 (SBP)

f 52 y

meningioma

skull base + orbita

CT

1,68

20

B2 (SBP)

m 67 y

prim. bone tumour

skull base + orbita

CT

2,05

21

C1 (BHP)

f 18 y

astrocytoma WHO II

left temporal

MRI

2,54

22

C1 (BHP)

m 56 y

astrocytoma WHO III

left temporal

MRI

1,87

23

C1 (BHP)

m 27 y

lymphoma

right parietal

MRI

1,57

24

C1 (BHP)

m 61 y

glioblastoma

left frontal

CT

1,21

25

C1 (BHP)

m 64 y

lymphoma

left temporal

MRI

1,17

26

C1 (BHP)

m 46 y

lymphoma

right temporal

MRI

1,30

27

C1 (BHP)

m 65 y

glioma WHO III

left temporal

MRI

2,98

28

C1 (TNA)

m 35 y

fibrous dysplasia

skull base

CT

1,32

29

C1 (TNA)

f 62 y

paraganglioma

right Fossa pterygopalatina

MRI

2.12

30

C1 (TNA)

m 54 y

fibrous dysplasia

skull base

CT

1,24

31

C2 (BHP)

m 64 y

lymphoma

left frontal

CT

1,33

32

C2 (BHP)

f 51 y

glioblastoma

left frontal

MRI

1,54

33

C2 (BHP)

m 54 y

astrocytoma WHO III

right frontal

MRI

1,87

34

C2 (BHP)

m 48 y

astrocytoma WHO II

left frontal

MRI

2,27

35

C2 (BHP)

m 65 y

metastasis

left frontal

CT

2,24

36

C2 (BHP)

f 70 y

glioblastoma

left temporal

MRI

1,56

37

C2 (AWC)

f 66 y

metastasis

left frontal

MRI

1,08

38

C2 (AWC)

m 26 y

glioma WHO III

left fronto-temporal

MRI

1,87

39

C2 (AWC)

f 63 y

glioma WHO III

left temporal

MRI

2,23

40

C2 (AWC)

m 56 y

glioma WHO III

left temporal

MRI

1,51

  1. m = male; f = female; y = years; FRE = Fiducial Registration Error
  2. Type A (control group) = 3-point-pin fixation; no DRF
  3. Type B 1 = 3-point-pin fixation; oral DRF; Type B 2 = 3-point-pin fixation; retroauricular DRF
  4. Type C 1 = unfixed head; oral DRF; Type C 2 = unfixed head; retroauricular DRF
  5. MLL = multilocular lesion; BHP = burr hole procedure for biopsy/endoscopy; SBP = Skull base procedure; TNA = transnasal approach; AWC = awake craniotomy